Polyrizon structures clinical strategy for its allergy blocker ahead of fda pre-submission meeting

Studies to assess efficacy, safety, user experience, and nasal residence time as company prepares for regulatory path forward
PLRZ Ratings Summary
PLRZ Quant Ranking